Arialys Therapeutics: Treating Autoimmune Neuropsychiatric Diseases

Citeline Podcasts - A podcast by Citeline

Categories:

In this episode of the In Vivo podcast, Peter Flynn, CEO of Arialys Therapeutics, discusses the exciting field of autoimmune neuropsychiatry and the company’s monoclonal antibody, which it is investigating for the treatment of a rare condition called anti-NMDA receptor encephalitis and potentially other indications.

Visit the podcast's native language site